MentalHealthDaily

Lateral Habenula & Depression: The Anti-Reward Center (Mechanisms & Antidepressant Treatments)

by GLOOM

Depression is a complex and multifaceted disorder affecting millions worldwide. Emerging evidence suggests the lateral habenula, a small brain region, plays a crucial role in depression’s development and persistence. By influencing neurotransmitter systems and interacting with stress pathways, the lateral habenula’s dysfunction may lead to the classic symptoms of depression. Highlights: The lateral habenula is …

Effects of Pramipexole on Reward Learning: Possible Depression Treatment? (2023 Study)

by GLOOM

In a significant stride toward understanding and treating depression, a 2023 study meticulously investigates the effects of pramipexole, a dopamine D2-like agonist, on reward learning. By exploring its impact on healthy volunteers through rigorous behavioral and neural assessments, the research offers groundbreaking insights into how this drug (occasionally used in depression) could revolutionize therapeutic strategies …

Top Antidepressants to Quit Smoking: Bupropion & Nortriptyline (2023 Evidence Review)

by GLOOM

In the ever-evolving fight against tobacco addiction, the potential of antidepressants, particularly bupropion and nortriptyline, as smoking cessation aids has come into sharp focus. A comprehensive review evaluated the efficacy, potential harms, and tolerability of these medications, providing insights into their role in helping smokers quit. Highlights: Bupropion significantly increases the chances of long-term smoking …

Cognitive Enhancement Effects of Caffeine, Methylphenidate, Modafinil (Study)

by GLOOM

In the pursuit of peak mental performance, scientific studies have explored the effects of stimulants like methylphenidate, modafinil, and caffeine on cognitive functions such as memory and attention. Recent research utilizing advanced neuroimaging techniques has begun to unravel the intricate ways these substances modulate brain activity and connectivity, offering insights into their potential as cognitive …

Exercise to Treat Depression: Aerobic & Resistance Training Effective Antidepressants?

by GLOOM

Exercise has emerged as an effective treatment for depression, rivaling medication and psychotherapy in its ability to reduce symptoms. Both aerobic and resistance training provide mental health benefits, with a combination of the two being optimal. However, exercise is vastly underutilized and more research is needed to uncover the mechanisms behind its antidepressant effects. Highlights: …

Depression Linked to 12 Gastrointestinal Diseases in Genetic Analysis Study

by GLOOM

A new study published in Translational Psychiatry found evidence that genetic predisposition to depression is associated with increased risks of 12 different gastrointestinal diseases, including irritable bowel syndrome, non-alcoholic fatty liver disease, gastroesophageal reflux disease, ulcerative colitis, and more. The study helps establish a causal relationship between depression and gastrointestinal disease risk while minimizing confounding …

Metformin Prevents Antipsychotic-Induced Weight Gain: A Saudi Study Finds

by GLOOM

Research suggests that metformin may reduce weight gain associated with antipsychotic medications. Key facts: Antipsychotics are linked to weight gain, especially clozapine and olanzapine. Metformin may counteract antipsychotic-induced weight gain through effects on insulin resistance and appetite. Study found metformin reduced mean weight gain on antipsychotics from 2.5 kg to -0.04 kg. Younger patients ages …